TSH Biopharm Corporation Limited

TSH Biopharm Corporation Limited is a specialty and generic drug manufacturer with a core focus on developing and marketing pharmaceutical products for the Taiwanese and Asian markets. Established in 1999 and headquartered in Taipei, the company’s portfolio addresses a range of therapeutic areas including cardiovascular, central nervous system, and gastrointestinal disorders. In addition to traditional medications, TSH Biopharm is involved in precision medical testing and has an active pipeline, with ongoing clinical trials and drug development especially within endocrinology and metabolic diseases. Its products include notable brands such as Amtrel and Rytmonorm, serving both clinical and retail market needs primarily within Taiwan. As a subsidiary of TTY Biopharm Company Limited, TSH Biopharm plays a strategic role in expanding healthcare innovation and pharmaceutical access in the region, contributing to advances in specialty treatments and supporting the broader industry’s growth through research, development, and commercialization activities.